These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8740006)

  • 41. Introduction of the gene amplification technique to decrease the risk of hepatitis C virus transmission by plasma products.
    Branović K; Forcis D; Kosutic-Gulija T; Santak M; Zgorelec R; Mazuran R
    J Chromatogr A; 1999 Aug; 852(1):305-12. PubMed ID: 10480255
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical performance of the new rRoche COBAS TaqMan HCV Test and High Pure System for extraction, detection and quantitation of HCV RNA in plasma and serum.
    Gelderblom HC; Menting S; Beld MG
    Antivir Ther; 2006; 11(1):95-103. PubMed ID: 16518965
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Elimination of false-negative hepatitis C virus RNA results by removal of inhibitors in cadaver-organ donor blood specimens.
    Padley DJ; Lucas SB; Saldanha J
    Transplantation; 2003 Jul; 76(2):432-4. PubMed ID: 12883207
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Testing of individual blood donations for HCV RNA reduces the residual risk of transfusion-transmitted HCV infection.
    Legler TJ; Riggert J; Simson G; Wolf C; Humpe A; Munzel U; Uy A; Köhler M; Heermann KH
    Transfusion; 2000 Oct; 40(10):1192-7. PubMed ID: 11061854
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatitis C viral RNA in serum of patients with chronic non-A, non-B hepatitis: detection by the polymerase chain reaction using multiple primer sets.
    Cristiano K; Di Bisceglie AM; Hoofnagle JH; Feinstone SM
    Hepatology; 1991 Jul; 14(1):51-5. PubMed ID: 1648539
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Inhibitory effects of therapeutic reagents on the PCR detection of hepatitis C virus in serum and their elimination by RNA extraction methods].
    Masukawa A; Miyachi H; Ohshima T; Ando Y
    Rinsho Byori; 1999 Oct; 47(10):949-55. PubMed ID: 10590669
    [TBL] [Abstract][Full Text] [Related]  

  • 47. World Health Organization collaborative study to calibrate the 3rd International Standard for Hepatitis C virus RNA nucleic acid amplification technology (NAT)-based assays.
    Baylis SA; Heath AB;
    Vox Sang; 2011 May; 100(4):409-17. PubMed ID: 21488880
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inter-laboratory comparison of qualitative and quantitative detection of hepatitis C (HCV) virus RNA in diagnostic virology: a multicentre study (MS) in Italy.
    Mancini C; Pisani G; Azzi A; Luisa Zerbini M; Gentili G; Mario Bisso G;
    J Clin Virol; 2004 Aug; 30(4):313-9. PubMed ID: 15163420
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Real-time multiplex PCR assay to quantify hepatitis C virus RNA in peripheral blood mononuclear cells.
    Pugnale P; Latorre P; Rossi C; Crovatto K; Pazienza V; Gottardi AD; Negro F
    J Virol Methods; 2006 May; 133(2):195-204. PubMed ID: 16384611
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with a low viral load.
    Katsoulidou A; Moschidis Z; Sypsa V; Chini M; Papatheodoridis GV; Tassopoulos NC; Mimidis K; Karafoulidou A; Hatzakis A
    Vox Sang; 2007 Jan; 92(1):8-14. PubMed ID: 17181585
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Distribution of hepatitis C virus in circulating blood components from blood donors.
    Chancey C; Winkelman V; Foley JB; Silberstein E; Teixeira-Carvalho A; Taylor DR; Rios M
    Vox Sang; 2012 Aug; 103(2):99-106. PubMed ID: 22404907
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Indeterminate RIBA results were associated with the absence of hepatitis C virus RNA (HCV-RNA) in blood donors.
    Pereira FM; Zarife MA; Reis EA; G Reis M
    Rev Soc Bras Med Trop; 2014; 47(1):12-7. PubMed ID: 24603731
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fully automated quantification of hepatitis C virus (HCV) RNA in human plasma and human serum by the COBAS AmpliPrep/COBAS TaqMan system.
    Sizmann D; Boeck C; Boelter J; Fischer D; Miethke M; Nicolaus S; Zadak M; Babiel R
    J Clin Virol; 2007 Apr; 38(4):326-33. PubMed ID: 17344093
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of automated RNA-extraction technology and a qualitative HCV assay for sensitivity and detection of HCV RNA in pool-screening systems.
    Beld M; Habibuw MR; Rebers SP; Boom R; Reesink HW
    Transfusion; 2000 May; 40(5):575-9. PubMed ID: 10827262
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of performances of VERSANT HCV RNA 1.0 assay (kPCR) and Roche COBAS AmpliPrep/COBAS TaqMan HCV test v2.0 at low level viremia.
    Mazzuti L; Lozzi MA; Riva E; Maida P; Falasca F; Antonelli G; Turriziani O
    New Microbiol; 2016 Jul; 39(3):224-227. PubMed ID: 27284986
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Simultaneous extraction of hepatitis C virus (HCV), hepatitis B virus, and HIV-1 from plasma and detection of HCV RNA by a reverse transcriptase-polymerase chain reaction assay designed for screening pooled units of donated blood.
    Sun R; Schilling W; Jayakar H; Ku J; Wang J; Rosenstraus M; Spadoro J
    Transfusion; 1999 Oct; 39(10):1111-9. PubMed ID: 10532606
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of the COBAS Hepatitis C Virus (HCV) TaqMan analyte-specific reagent assay and comparison to the COBAS Amplicor HCV Monitor V2.0 and Versant HCV bDNA 3.0 assays.
    Konnick EQ; Williams SM; Ashwood ER; Hillyard DR
    J Clin Microbiol; 2005 May; 43(5):2133-40. PubMed ID: 15872232
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of quantitative HCV RNA assays in chronic hepatitis C.
    Jacob S; Baudy D; Jones E; Xu L; Mason A; Regenstein F; Perrillo RP
    Am J Clin Pathol; 1997 Mar; 107(3):362-7. PubMed ID: 9052389
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Experiences with genetic screening for established and new agents.
    Barbara J
    Dev Biol (Basel); 2000; 102():99-103. PubMed ID: 10794095
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Evaluation of the diagnostic efficacy of a test system for detecting hepatitis virus C RNA by polymerase chain reaction "AmpliSens(TM) HCV-240/BKO-440)"].
    Bektimirov TA; Volkova RA; El'bert EV; Shalunova NV; Chulanov VP; Gorbunov MA; Nikitiuk NM; Shipulin GA; Shipulina OIu; Bocharova NG; Musina EE
    Vopr Virusol; 2002; 47(5):12-6. PubMed ID: 12522962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.